|
|
Volumn 275, Issue 11, 1996, Pages 823-824
|
|
Reflecting and regrouping after failed trials, sepsis researchers forge on
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BACTERIUM LIPOPOLYSACCHARIDE;
CYTOKINE;
E 5531;
ENDOTOXIN;
ENDOTOXIN ANTIBODY;
HIGH DENSITY LIPOPROTEIN;
INTERLEUKIN 1;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
INTERLEUKIN 6;
INTERLEUKIN 8;
LIPID A DERIVATIVE;
MONOCLONAL ANTIBODY;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANTIINFLAMMATORY ACTIVITY;
ARTERIAL PRESSURE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
EXPERIMENTAL MODEL;
HUMAN;
HYPOTHESIS;
MEDIATOR RELEASE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
SEPSIS;
SEPTIC SHOCK;
|
|
EID: 0030010164
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.275.11.823 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|